ARCHIVES

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

This article is from The Cancer Letter archive.

Vol. 20 No. 06 | February 11, 1994

Download PDF Visit The Full Archive

Related Articles

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups

September 30, 1988

DCPC Board Approves Concepts Of Six New RFAs Totaling $9.3 Million A Year

May 11, 1984

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants

March 13, 1981

Gio Gori And The “Tolerable” Smoking Flap; Controversy When He Needs It Least

August 18, 1978